Challenge IM to Showcase Integrated Bioprocess Solutions at CPHI China 2026

SHANGHAI, China — Challenge IM , a leading pioneer in advanced fluid separation and membrane filtration technologies, today announced its upcoming participation in CPHI China 2026. The premier pharma industry event in Asia will be held from June 16 to 18, 2026, at the Shanghai New International Expo Centre (SNIEC).

Guided by its core mission—"Advancing Membrane Filtration · Safeguarding Biopharma"—Challenge IM is set to showcase its latest portfolio of cutting-edge downstream purification solutions tailored to meet the evolving regulatory and operational demands of the global biopharmaceutical sector.